NCT06757010Phase 2Completed

A Study of NE3107 in Early Parkinson's

Study sponsor: BioVie Inc. · BIVI

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-05-01Actual
Enrollment · participants57Actual
Source updated2026-08-11Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from baseline in the MDS-UPDRS Part III. After: Measure: Monocyte Lymphocyte Ratio (MLR).

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 57 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 2 fields changed

Primary completion date changed

Before: 1 Dec 2025. After: 1 May 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview